9
Publications
95
Stories per week
11
Expert Writers
950,000
Subscribers

Everybody follows what’s happening. Our editors know what it means.

Learn More

More than 1,000,000 industry decision-makers and influencers turn here all year to keep up with the Life Sciences market and ahead of the competition.

Learn More

Explore Our Life Sciences Publications
Biotech FierceBiotechIT

Target Audience

Professional Audience
A global community of drug development professionals, market analysts and investors, focused on the C-suite, but broadly relevant to everyone who has a professional role or interest in drug development, primarily in the U.S., with a growing emphasis on Europe and Asia. 

Content Focus
Full spectrum clinical stage drug development, deals and data on the most compelling therapies in the pipeline, the ongoing restructuring of the industry’s R&D efforts, with a sharp focus on leadership.

25
Stories per week
2
Expert Writers
163000
Subscribers
Daily
Frequency
Pharma FiercePharma

Target Audience

Professional Audience
Wide range of drug company executives from the C-suite to sales reps and manufacturing managers. Readership also includes contractors and others with a professional interest in the pharma industry. U.S. represents the largest audience segment followed by U.K. and Indian markets. Readership in other European and Asian markets is growing rapidly, particularly in countries with big concentrations of pharma companies, such as Germany, Denmark, France, China and Japan.

Content Focus
Broad coverage serving a wide range of specific functional interests including: manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline and the influence of big data, executive moves and social media on it all.

25
Stories per week
3
Expert Writers
171000
Subscribers
Daily
Frequency
Medical Devices FierceMedicalDevices

Target Audience

Professional Audience
Medical device executives and entrepreneurs are the core audience, with additional readership from service sectors such as its investors, lawyers and accountants.

Content Focus 
Emerging technologies such as wireless connectivity, advanced materials, nanotechnology and biological materials, and the regulatory, market, legal and financial issues and dynamics driving the sector.

15
Stories per week
1
Expert Writers
94000
Subscribers
Three Times per Week
Frequency
Biotech Research FierceBiotech Research

Target Audience

Professional Audience
A mix of industry and academic researchers who lead much of this work along with the large contingent of biotech executives and venture players looking to invest in next-gen therapies. 

Content Focus
New companies, therapies and technologies, government funding for preclinical research, NIH grants, early-stage biotech work, animal studies and alternative funding mechanisms for drug research.

4
Stories per week
1
Expert Writer
56000
Subscribers
Weekly
Frequency
Pharma Manufacturing PharmaManufacturing

Target Audience

Professional Audience
C-level executives overseeing manufacturing and quality control concerns, mid-level management tied to plants and supply chain responsibilities, drug wholesalers, healthcare executives concerned with drug shortages, investors and consultants.  
 
Content Focus
Technology, science, efficiency, regulation, leadership and their impact on competition.

12
Stories per week
1
Expert Writer
40000
Subscribers
Twice per Week
Frequency
Pharma Marketing FiercePharmaMarketing

Target Audience

Professional Audience
Drug company marketing teams and brand managers, sales managers and sales reps, C-suite, plus advertising and media agencies, sales and marketing consultants, and others with a professional interest in pharma marketing. The U.S. represents the largest readership segment, followed by Asia and Europe.

Content Focus
Competition and rivalries as new therapies near market, availability and market impact of new research data, DTC campaigns and disease-awareness efforts, sales and marketing strategies for reaching physicians and relieving pressure from payers, the “empowered patient” affect, how technology and innovation such as big data, social media, new sensor/tracking technologies, and narrowly targeted marketing and advertising mechanisms are changing the game.

12
Stories per week
3
Expert Writers
30000
Subscribers
Twice per Week
Frequency
CRO FierceCRO

Target Audience

Professional Audience
Employees at contract R&D organizations. FierceCRO focuses on C-suite execs, and attracts a wide readership of middle managers and members of research teams. 

Content Focus
Deals and partnerships between CROs and drugmakers, financial results, new analytical technologies, changing regulations, consolidation and M&A, contract manufacturers, preclinical service providers and academic institutions that carry out contract work.

6
Stories per week
1
Expert Writer
25000
Subscribers
Weekly
Frequency
Vaccines FierceVaccines

Target Audience

Professional Audience 
High-level execs in the vaccine industry, either in development, industry or sales, who are closely tracking R&D and market developments. 

Content Focus
Discovery and development, venture capital and finance, clinical trials, regulatory affairs, manufacturing, licensing and M&A, and sales and marketing across a broad range of patient needs and market conditions.

6
Stories per week
2
Expert Writers
30000
Subscribers
Weekly
Frequency
Life Sciences Editorial Staff
 Beth Snyder Bulik
Beth Snyder Bulik Contributing Writer

Beth Snyder Bulik

Contributing Writer

Beth Snyder Bulik writes for FiercePharmaMarketing. She has been a freelance journalist for 12 years, contributing to publications including Advertising Age, AmericanWay and American Baby. Before that, she was a senior writer at Business 2.0, and held reporting positions at Advertising Age, Telephony magazine and Texas Business. She is currently based in Pennsylvania, near Philadelphia, and can be reached at [email protected], or find her on LinkedIn.

Nick Taylor
Nick Taylor Contributing Writer

Nick Taylor

Contributing Writer

Nick Taylor is a freelance journalist with more than 6 years' experience of reporting on the global biopharma industry. Since graduating with a biology degree from the University of York, Nick has written for numerous healthcare publications, including Nature BioPharma Dealmakers, Life Science Leader and Outsourcing-Pharma. You can contact him at [email protected]

Arlene Weintraub
Arlene Weintraub Contributing Writer

Arlene Weintraub

Contributing Writer

Arlene Weintraub is a science journalist and author with 20 years of experience writing about health care, pharmaceuticals and biotechnology. Her most recent book, Heal: The Vital Role of Dogs in the Search for Cancer Cures (ECW Press 2015), brings to life the world of comparative oncology and the many ways dogs are helping in the war against cancer. Her freelance pieces have been published in the New York Times, US News & World Report, Technology Review, Scientific American, USA Today, and other media outlets. She was previously a senior health writer for BusinessWeek, covering both the science and business of health. She has won awards from the New York Press Club, the Association of Health Care Journalists, the Foundation for Biomedical Research, and the American Society of Business Publication Editors. Her book about the antiaging industry, Selling the Fountain of Youth, was published by Basic Books in 2010.

Tracy Staton
Tracy Staton Editor-in-Chief

Tracy Staton

Editor-in-Chief

Tracy Staton is the editor of FiercePharma and FiercePharmaMarketing. She has been a freelance writer for 8 years. Before that, she served as editor of the Dallas Business Journal, editor of Texas Business magazine, and a senior editor at American Way, the inflight magazine of American Airlines. She is based in Vermont and can be reached at [email protected], or find her on LinkedIn.

Eric Palmer
Eric Palmer Senior Editor

Eric Palmer

Senior Editor

Eric Palmer is a business and technology journalist with more than three decades of prize-winning experience as a reporter and editor with daily, weekly, monthly and online publications. He was healthcare reporter for The Kansas City Star before becoming deputy business editor for the daily newspaper. He spent 8 years as editor of The Kansas City Business Journal, which had a strong emphasis on the healthcare industry. He is an avid fly fisherman, cooks and collects wine, and likes to travel with his family. Eric is based in Kansas City and can be reached at [email protected]

Carly Helfand
Carly Helfand Editor

Carly Helfand

Editor

Carly Helfand is a news editor with FierceMarkets' Life Sciences group, writing for FierceVaccines, FiercePharma and FiercePharmaMarketing. Carly got her start covering pharma while earning her master's at Northwestern University's Medill School of Journalism, where she concentrated in business reporting. She has completed journalism projects on four continents, and her work has appeared in various outlets such as The Boston Globe, The Washington Post's Wonkblog and Cape Town's Weekend Argus. Carly prefers watching pro hockey to nearly everything. She also plays the Irish fiddle. You can contact her at [email protected]

Ben Adams
Ben Adams Editor

Ben Adams

Editor

Ben Adams is a business, science and healthcare journalist who has worked as an editor for the UK publication Pharmafocus and as a group editor Pharmaceutical Marketing Europe, as well as a features and news writer for the BMJ and the Pharmaceutical Journal. He has an especial interest in market access, drug pricing and the ethics of the life sciences industry and has been heavily involved in ensuring the need for greater clinical study transparency remains on the agenda for the industry. On the personal side, he enjoys reading esoteric pieces of literary fiction from Charles Williams, Will Self, Ros Barber and Milan Kundera, and is currently awaiting the publication of his own set of literary juvenilia, coming to a second-hand bookshop no-where near anyone soon. Ben is based on the south coast of England and can be reached at [email protected]

Amirah Al Idrus
Amirah Al Idrus Associate Editor

Amirah Al Idrus

Associate Editor

Amirah Al Idrus is a copy editor for the FierceMarkets Life Sciences group and a contributing writer for FierceVaccines. Before joining the Fierce Life Sciences team, Amirah completed a master's degree in journalism at the University of Maryland, where she concentrated in online and multimedia journalism. While at Maryland, she worked for the university's Capital News Service as a web designer and developer, and interned at the Washington Business Journal. She has covered issues ranging from Maryland politics and local business to finance in state prisons. When she's not working, Amirah spends her time running around D.C. and Silver Spring, visiting museums, and baking (and eating) pies. She can be reached at [email protected]

Eric Sagonowsky
Eric Sagonowsky Associate Editor

Eric Sagonowsky

Associate Editor

Eric Sagonowsky is an associate editor with the FierceMarkets Life Sciences team. Before joining Fierce in November 2014, Eric worked as a news reporter for theManistee News Advocate in Manistee, Mich., covering government and crime issues. Eric graduated from Ohio University's E.W. Scripps School of Journalism in 2012 with a degree in Online Journalism. On campus, Eric wrote for The Athens News and The New Political. In his free time, Eric enjoys outdoor recreation, following sports of all kinds and exploring the metro D.C. area. He can be reached [email protected] Follow @EricSFierce on Twitter.

Angus Liu
Angus Liu Associate Editor

Angus Liu

Associate Editor

You're mobile. So are we.

FierceBiotech

Includes the following publications:

  • FierceBiotechIT
  • FiercePharma

    Includes the following publications:

  • FiercePharma